Cite

HARVARD Citation

    Barber, D. et al. (2019). GRAZAX®: a sublingual immunotherapy vaccine for Hay fever treatment: from concept to commercialization. Human vaccines & immunotherapeutics. 15 (12), pp. 2887-2895. [Online]. 
  
Back to record